Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo

1M ago

LXRX

PremiumCompany Announcements

Lexicon Pharmaceuticals Launches Strategic Private Placement

1M ago

LXRX

PremiumPress Releases

Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update

1M ago

LXRX

PremiumPress Releases

Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities

1M ago

LXRX

PremiumPress Releases

Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference

4M ago

LXRX

PremiumPress Releases

Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)

5M ago

LXRX

More LXRX News >

LXRX News on the Web

2024-04-23

Needham Keeps Their Hold Rating on Lexicon Pharmaceuticals (LXRX)

TipRanks News

Neutral

2024-04-18

Lexicon Pharmaceuticals to Host 2024 Investor Day

Yahoo Finance

Neutral

2024-04-16

All You Need to Know About Lexicon Rating Upgrade to Buy

Yahoo Finance

Bullish

2024-04-16

All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy

Zacks

Bullish

2024-04-03

Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Yahoo Finance

Neutral

2024-03-27

Is Lexicon Pharmaceuticals Inc (LXRX) Stock a Bad Value Wednesday?

Investors Observer

Neutral

2024-03-25

Is Lexicon Pharmaceuticals Inc (LXRX) a Leader in the Biotechnology Industry?

Investors Observer

Neutral

2024-03-25

Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

LXRX

Sector Average

Media Buzz

This Week2 articles

Weekly Average1.25 articles

News Sentiment

This Week50%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LXRX’s Media Buzz Sentiment?

2 articles about LXRX were published this week. In an average week, 1.25 articles are published.

What is LXRX’s weekly average amount of articles?

In an average week, 1.25 articles about LXRX are published.

What is LXRX’s News Sentiment?

50% of articles about LXRX were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

IMVTImmunovant

RVVRevive Therapeutics

NVSNovartis

ISRGIntuitive Surgical

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing